Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib
PumaBiotech (@pumabiotech) / Twitter
Why Puma Biotechnology Shares Dropped 17.7% This Week | The Motley Fool
Puma Biotechnology
PumaBiotech (@pumabiotech) / Twitter
SEC charges former Puma biotech exec with $1.1 million in insider trading
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotech shares slide after glimpse of trial data on cancer drug | Financial Times
Puma Biotechnology
Puma Biotechnology
Puma Biotechnology and Bixink Therapeutics Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in South Korea | Business Wire